Implementation of an Electronic Medical Record Clinical Reminder for Pre-Exposure Prophylaxis (PrEP) Treatment for Human Immunodeficiency Virus (HIV)
Abstract
Pre-exposure prophylaxis (PrEP) is a treatment method that consists of medications taken to decrease the risk of contracting and transmitting Human Immunodeficiency Virus (HIV) (Becquet et al., 2021; Centers for Disease Control [CDC], 2023a; Davis et al., 2023). PrEP is recommended and highly effective for preventing HIV when taken as prescribed in uninfected high-risk individuals, including men having sex with men, and people who inject drugs (PWID) (Centers for Disease Control [CDC], 2024a.; Cooper et al., 2021; Davis et al., 2023; O’Byrne et al., 2019; Rutstein et al., 2020; Storholm et al., 2021; Zhang et al., 2020). PrEP reduces the risk of getting HIV from injection drug use by 74% to about 84% and from sex by 99% (CDC, 2023a.; Dubov, et al., 2023; Walters et al., 2022). Despite the proven effectiveness of PrEP and the 1.2 million adults in the United States who would benefit from PrEP, only 80,000 high-risk people who could benefit from PrEP treatment are taking PrEP (Petroll et al., 2017). This DNP project utilizes the PrEP assessment tool from the New York Department of Health to assess a high-risk population of people who use drugs (PWUDs) and identify risk factors for HIV and PrEP eligibility. Based on these findings, the use of a clinical reminder is proposed to prompt healthcare providers to complete HIV screening, increase the prevalence of PrEP use, and potentially decrease the incidence of HIV. This supports the Health and Human Services Ending the HIV Epidemic (EHE) Initiative to reduce new HIV infections by 75% by 2025 and 90% by 2030 (Fauci et al., 2019; Hamilton et al.,2023).
Disciplines
Epidemiology | Medicine and Health Sciences | Nursing | Public Health
Subject Area
Nursing; Public health; Health sciences; Epidemiology
Recommended Citation
Wegman, Mary Kay, "Implementation of an Electronic Medical Record Clinical Reminder for Pre-Exposure Prophylaxis (PrEP) Treatment for Human Immunodeficiency Virus (HIV)" (2024). Doctoral Dissertations. 220.
https://digitalcommons.salve.edu/doctoral_dissertations/220
Department
Nursing (NUR)
First Advisor
Cherubini, Debra
Second Advisor
Fairbanks, Clarisse
Third Advisor
Frank, Cynthia
Date of Award
8-2024
Document Type
Dissertation
Degree Name
D.N.P.
